Search Results - "Groarke, John"

Anthracycline Cardiotoxicity: A New Paradigm for an Old Classic by Groarke, John D, Nohria, Anju

Get full text

Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction by Taqueti, Viviany R, Solomon, Scott D, Shah, Amil M, Desai, Akshay S, Groarke, John D, Osborne, Michael T, Hainer, Jon, Bibbo, Courtney F, Dorbala, Sharmila, Blankstein, Ron, Di Carli, Marcelo F

“…Abstract Aims Coronary microvascular ischaemia, cardiomyocyte injury and stiffness may play an important role in the pathophysiology of heart failure with…”
Get full text

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association by Campia, Umberto, Moslehi, Javid J., Amiri-Kordestani, Laleh, Barac, Ana, Beckman, Joshua A., Chism, David D., Cohen, Paul, Groarke, John D., Herrmann, Joerg, Reilly, Carolyn M., Weintraub, Neal L.

“…Cardio-oncology has organically developed as a new discipline within cardiovascular medicine as a result of the cardiac and vascular adverse sequelae of the…”
Get full text

Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis by Zhang, Lili, Zlotoff, Daniel A., Awadalla, Magid, Mahmood, Syed S., Nohria, Anju, Hassan, Malek Z.O., Thuny, Franck, Zubiri, Leyre, Chen, Carol L., Sullivan, Ryan J., Alvi, Raza M., Rokicki, Adam, Murphy, Sean P., Jones-O’Connor, Maeve, Heinzerling, Lucie M., Barac, Ana, Forrestal, Brian J., Yang, Eric H., Gupta, Dipti, Kirchberger, Michael C., Shah, Sachin P., Rizvi, Muhammad A., Sahni, Gagan, Mandawat, Anant, Mahmoudi, Michael, Ganatra, Sarju, Ederhy, Stephane, Zatarain-Nicolas, Eduardo, Groarke, John D., Tocchetti, Carlo G., Lyon, Alexander R., Thavendiranathan, Paaladinesh, Cohen, Justine V., Reynolds, Kerry L., Fradley, Michael G., Neilan, Tomas G.

Get full text

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors by Mahmood, Syed S., Fradley, Michael G., Cohen, Justine V., Nohria, Anju, Reynolds, Kerry L., Heinzerling, Lucie M., Sullivan, Ryan J., Damrongwatanasuk, Rongras, Chen, Carol L., Gupta, Dipti, Kirchberger, Michael C., Awadalla, Magid, Hassan, Malek Z.O., Moslehi, Javid J., Shah, Sachin P., Ganatra, Sarju, Thavendiranathan, Paaladinesh, Lawrence, Donald P., Groarke, John D., Neilan, Tomas G.

“…Myocarditis is an uncommon, but potentially fatal, toxicity of immune checkpoint inhibitors (ICI). Myocarditis after ICI has not been well characterized. The…”
Get full text

Cardiovascular Toxicities Associated With Ibrutinib by Salem, Joe-Elie, Manouchehri, Ali, Bretagne, Marie, Lebrun-Vignes, Bénédicte, Groarke, John D., Johnson, Douglas B., Yang, Tao, Reddy, Nishitha M., Funck-Brentano, Christian, Brown, Jennifer R., Roden, Dan M., Moslehi, Javid J.

“…Ibrutinib has revolutionized treatment for several B-cell malignancies. However, a recent clinical trial where ibrutinib was used in a front-line setting…”
Get full text

Cardiovascular vulnerability of childhood cancer survivors: time to progress from risk observation to risk modification by Groarke, John D

“…Abstract Take home figure Modifiers of the association of childhood cancer therapies and excess CV risk observed in adult survivors, together with promising…”
Get full text

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society by Lyon, Alexander R., Dent, Susan, Stanway, Susannah, Earl, Helena, Brezden‐Masley, Christine, Cohen‐Solal, Alain, Tocchetti, Carlo G., Moslehi, Javid J., Groarke, John D., Bergler‐Klein, Jutta, Khoo, Vincent, Tan, Li Ling, Anker, Markus S., Haehling, Stephan, Maack, Christoph, Pudil, Radek, Barac, Ana, Thavendiranathan, Paaladinesh, Ky, Bonnie, Neilan, Tomas G., Belenkov, Yury, Rosen, Stuart D., Iakobishvili, Zaza, Sverdlov, Aaron L., Hajjar, Ludhmila A., Macedo, Ariane V.S., Manisty, Charlotte, Ciardiello, Fortunato, Farmakis, Dimitrios, Boer, Rudolf A., Skouri, Hadi, Suter, Thomas M., Cardinale, Daniela, Witteles, Ronald M., Fradley, Michael G., Herrmann, Joerg, Cornell, Robert F., Wechelaker, Ashutosh, Mauro, Michael J., Milojkovic, Dragana, Lavallade, Hugues, Ruschitzka, Frank, Coats, Andrew J.S., Seferovic, Petar M., Chioncel, Ovidiu, Thum, Thomas, Bauersachs, Johann, Andres, M. Sol, Wright, David J., López‐Fernández, Teresa, Plummer, Chris, Lenihan, Daniel

“…This position statement from the Heart Failure Association of the European Society of Cardiology Cardio‐Oncology Study Group in collaboration with the…”
Get full text

Management of acute coronary syndromes in patients with cancer: room for improvement by Nohria, Anju, Groarke, John D

“…Abstract…”
Get full text

Cancer-Drug Discovery and Cardiovascular Surveillance by Groarke, John D, Cheng, Susan, Moslehi, Javid

“…The story of impressive evolution in treatment for chronic myeloid leukemia has taken an unexpected turn, as serious adverse cardiovascular events have…”
Get full text

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis by Zhang, Lili, Awadalla, Magid, Mahmood, Syed S, Nohria, Anju, Hassan, Malek Z O, Thuny, Franck, Zlotoff, Daniel A, Murphy, Sean P, Stone, James R, Golden, Doll Lauren Alexandra, Alvi, Raza M, Rokicki, Adam, Jones-O'Connor, Maeve, Cohen, Justine V, Heinzerling, Lucie M, Mulligan, Connor, Armanious, Merna, Barac, Ana, Forrestal, Brian J, Sullivan, Ryan J, Kwong, Raymond Y, Yang, Eric H, Damrongwatanasuk, Rongras, Chen, Carol L, Gupta, Dipti, Kirchberger, Michael C, Moslehi, Javid J, Coelho-Filho, Otavio R, Ganatra, Sarju, Rizvi, Muhammad A, Sahni, Gagan, Tocchetti, Carlo G, Mercurio, Valentina, Mahmoudi, Michael, Lawrence, Donald P, Reynolds, Kerry L, Weinsaft, Jonathan W, Baksi, A John, Ederhy, Stephane, Groarke, John D, Lyon, Alexander R, Fradley, Michael G, Thavendiranathan, Paaladinesh, Neilan, Tomas G

“…Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data exist on the use of cardiovascular magnetic resonance (CMR)…”
Get full text

Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis by Awadalla, Magid, Mahmood, Syed S., Groarke, John D., Hassan, Malek Z.O., Nohria, Anju, Rokicki, Adam, Murphy, Sean P., Mercaldo, Nathaniel D., Zhang, Lili, Zlotoff, Daniel A., Reynolds, Kerry L., Alvi, Raza M., Banerji, Dahlia, Liu, Shiying, Heinzerling, Lucie M., Jones-O’Connor, Maeve, Bakar, Rula B., Cohen, Justine V., Kirchberger, Michael C., Sullivan, Ryan J., Gupta, Dipti, Mulligan, Connor P., Shah, Sachin P., Ganatra, Sarju, Rizvi, Muhammad A., Sahni, Gagan, Tocchetti, Carlo G., Lawrence, Donald P., Mahmoudi, Michael, Devereux, Richard B., Forrestal, Brian J., Mandawat, Anant, Lyon, Alexander R., Chen, Carol L., Barac, Ana, Hung, Judy, Thavendiranathan, Paaladinesh, Picard, Michael H., Thuny, Franck, Ederhy, Stephane, Fradley, Michael G., Neilan, Tomas G.

“…There is a need for improved methods for detection and risk stratification of myocarditis associated with immune checkpoint inhibitors (ICIs). Global…”
Get full text

Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction by Nadruz, Wilson, West, Erin, Sengeløv, Morten, Santos, Mário, Groarke, John D., Forman, Daniel E., Claggett, Brian, Skali, Hicham, Shah, Amil M.

“…Background This study aimed to compare the independent and incremental prognostic value of peak oxygen consumption (VO2) and minute ventilation/carbon dioxide…”
Get full text

Timing and Causes of Readmission after Acute Heart Failure Hospitalization – Insights from the Heart Failure Network Trials by Vader, Justin M., MD, MPHS, LaRue, Shane J., MD, MPHS, Stevens, Susanna R., MS, Mentz, Robert J., MD, DeVore, Adam D., MD, Lala, Anuradha, MD, Groarke, John D., MB, MPH, AbouEzzeddine, Omar F., MD, Dunlay, Shannon M., MD, MS, Grodin, Justin L., MD, Dávila-Román, Victor G., MD, de las Fuentes, Lisa, MD, MS

“…Highlights • Early readmission after heart failure hospitalization was often due to cardiovascular comorbidity. • ACE/ARB use was associated with lesser risk…”
Get full text

Cancer cachexia: getting to the heart of the matter by Groarke, John D, Cheng, Susan, Jones, Lee W, Moslehi, Javid

Get full text

Risk of mortality in older adults with loss of appetite: An analysis of Medicare fee-for-service data by Dagenais, Simon, Clark, Sunday, Fielding, Roger A., Cantu, Cera, Prasad, Sapna, Dai, Feng, Groarke, John D.

“…Prior research suggested that loss of appetite (LOA) among adults with Medicare fee-for-service (FFS) insurance in the United States increased the risk of…”
Get full text

Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease by Groarke, John D, Nguyen, Paul L, Nohria, Anju, Ferrari, Roberto, Cheng, Susan, Moslehi, Javid

“…Radiation exposure to the thorax is associated with substantial risk for the subsequent development of cardiovascular disease. Thus, the increasing role of…”
Get full text

Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes by Platz, Elke, Campbell, Ross T, Claggett, Brian, Lewis, Eldrin F, Groarke, John D, Docherty, Kieran F, Lee, Matthew M Y, Merz, Allison A, Silverman, Montane, Swamy, Varsha, Lindner, Moritz, Rivero, Jose, Solomon, Scott D, McMurray, John J V

“…OBJECTIVESThis study sought to assess the prevalence, changes in, and prognostic importance of B-lines, a pulmonary congestion measure by using a simplified…”
Get full text

Ibrutinib-Associated Atrial Fibrillation by Ganatra, Sarju, Sharma, Ajay, Shah, Sachin, Chaudhry, Ghulam M., Martin, David T., Neilan, Tomas G., Mahmood, Syed Saad, Barac, Ana, Groarke, John D., Hayek, Salim S., Dani, Saurbha, Venesy, David, Patten, Richard, Nohria, Anju

“…Ibrutinib, a novel and potent Bruton tyrosine kinase inhibitor, is an effective and well-tolerated treatment for a variety of B-cell lymphomas. However, its…”
Get full text

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis by Drobni, Zsofia D, Zafar, Amna, Zubiri, Leyre, Zlotoff, Daniel A, Alvi, Raza M, Lee, Charlotte, Hartmann, Sarah, Gilman, Hannah K, Villani, Alexandra-Chloe, Nohria, Anju, Groarke, John D, Sullivan, Ryan J, Reynolds, Kerry L, Zhang, Lili, Neilan, Tomas G

“…Background Myocarditis attributable to immune checkpoint inhibitor (ICI) therapy is a potentially fatal immune-related adverse event. Limited data have…”
Get full text